Association of nutritional indices with early clinical remission in patients with moderate-to-severe ulcerative colitis treated with vedolizumab

Hao Zhang, Yueyuan Wang, Jun Wu, Hongying Wang, Congcong Min, Pin Meng, Hua Liu, Tao Mao, Yonghong Xu, Lixin Jin, Baihui Wang, Xiaonan Han, Ailing Liu, Xueli Ding

Open source

DOI
10.1177/17562848261486841
Published
2026-07
Container
Therapeutic Advances in Gastroenterology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17562848261486841,
  title = {Association of nutritional indices with early clinical remission in patients with moderate-to-severe ulcerative colitis treated with vedolizumab},
  author = {Hao Zhang and Yueyuan Wang and Jun Wu and Hongying Wang and Congcong Min and Pin Meng and Hua Liu and Tao Mao and Yonghong Xu and Lixin Jin and Baihui Wang and Xiaonan Han and Ailing Liu and Xueli Ding},
  year = {2026},
  journal = {Therapeutic Advances in Gastroenterology},
  doi = {10.1177/17562848261486841},
  url = {https://doi.org/10.1177/17562848261486841}
}

RIS

TY  - JOUR
TI  - Association of nutritional indices with early clinical remission in patients with moderate-to-severe ulcerative colitis treated with vedolizumab
AU  - Hao Zhang
AU  - Yueyuan Wang
AU  - Jun Wu
AU  - Hongying Wang
AU  - Congcong Min
AU  - Pin Meng
AU  - Hua Liu
AU  - Tao Mao
AU  - Yonghong Xu
AU  - Lixin Jin
AU  - Baihui Wang
AU  - Xiaonan Han
AU  - Ailing Liu
AU  - Xueli Ding
PY  - 2026
JO  - Therapeutic Advances in Gastroenterology
DO  - 10.1177/17562848261486841
UR  - https://doi.org/10.1177/17562848261486841
ER  - 

APA

Zhang, H., Wang, Y., Wu, J., Wang, H., Min, C., Meng, P., Liu, H., Mao, T., Xu, Y., Jin, L., Wang, B., Han, X., Liu, A., & Ding, X. (2026). Association of nutritional indices with early clinical remission in patients with moderate-to-severe ulcerative colitis treated with vedolizumab. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/17562848261486841

Source records